Breaking Update
Scopio Labs Gets Fourth FDA OK for Blood Analysis Tech
Israeli health tech firm Scopio Labs has received its fourth U.S. Food and Drug Administration clearance, expanding the AI tools on its ...
Jerusalem, 13 July, 2025 (TPS-IL) — Israeli health tech firm Scopio Labs has received its fourth U.S. Food and Drug Administration clearance, expanding the AI tools on its digital blood analysis platforms. The Tel Aviv-based company’s updated system helps labs better analyze red blood cells and spot platelet clumps in blood samples.
“These upgrades make digital blood analysis faster and more consistent,” said CEO Itai Hayut.
Scopio’s technology scans thousands of cells and gives AI-powered results, while still letting lab professionals make the final call. The new clearance helps the company increase its presence in U.S. labs.
